Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Just Salad Opens in Milford, Conn.
GlobeNewswire, Inc.
Key facts of this press release: Milford, Conn., June 18, 2026 (GLOBE NEWSWIRE) -- Just Salad, the fast-casual restaurant chain committed to making everyday health and sustainability possible, introduces its new location in Milford, Conn., located...
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
GlobeNewswire, Inc.
Inmazeb® (a three-antibody cocktail consisting of maftivimab, atoltivimab and odesivimab-ebgn) was the first Ebola treatment approved by the U.S. Food and Drug Administration, indicated specifically for the Orthoebolavirus zairense species, and...
Aktis Oncology to Present at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those...
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
Press release – No. 11 / 2026 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, May 27, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of...
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GlobeNewswire, Inc.
BOSTON, May 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that...
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Erik Ostrowski, Chief...
Innovative, Life Changing TMS Therapy at Northeast Health Services' Boston Government Center Clinic
EIN Presswire
Northeast Health Services now offers NeuroStar TMS therapy in Boston, providing an innovative, non-drug treatment for depression.
Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology
GlobeNewswire, Inc.
Phase 1 data support TNX-1500 as a potentially first-in-class, best-in-class, third-generation anti-CD40L monoclonal antibody for the prevention of kidney transplant rejection Phase 2 investigator-initiated study in adult kidney transplant at...
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
GlobeNewswire, Inc.
Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater presentation and poster sessions...
Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis
GlobeNewswire, Inc.
RTY-406 demonstrates significant improvements in disease relevant endpoints in a mouse model of primary sclerosing cholangitis (PSC) and proof of mechanism in non-human primates RTY-406 is in Phase 1 clinical development as a potential...
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
GlobeNewswire, Inc.
BOTHELL, Wash., May 27, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it will...
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
GlobeNewswire, Inc.
Company announcement – No. 17 / 2026 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 Copenhagen, Denmark, May 26, 2026 - Zealand Pharma A/S ("Zealand Pharma" or the “Company”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
GlobeNewswire, Inc.
Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
New Report Shows The Parmenter Foundation 5-Year Impact on Grief and End-of-Life Support
EIN Presswire
Nearly 70,000 individuals reached as Parmenter supports creation of 20 new programs addressing unmet community needs WAYLAND, MA, UNITED STATES, June 18, 2026 /EINPresswire.com/ -- After identifying critical gaps in grief and end-of-life support...
Korro to Present at the 2026 Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
CAMBRIDGE, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to develop a new class of genetic medicines for...
Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
WATERTOWN, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced...
Cabot Corporation Earns EcoVadis Platinum Rating for Sixth Consecutive Year
GlobeNewswire, Inc.
BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) has earned a platinum rating from EcoVadis, the highest recognition available, for the sixth consecutive year.
Corporate Insight Releases Report on Health Plan Cost Estimators: As Price Transparency Pressure Mounts, Member Experience Gaps Remain Wide
GlobeNewswire, Inc.
New York, NY, May 26, 2026 (GLOBE NEWSWIRE) -- Corporate Insight (CI), the leading provider of competitive intelligence and customer experience research to the financial services, insurance and healthcare industries, today announced findings from...
Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
GlobeNewswire, Inc.
Data affirms Corbus strategy of targeting tumor types with elevated Nectin-4 expression and clear unmet medical needs while providing an attractive commercial path forward Confirmed ORR of 42.9% observed in 2L oropharyngeal squamous cell carcinoma...
5 Takeaways from Boston's first Air Quality Summit
City of Boston
2. Follow community knowledge about where air quality problems need solving.
Sign up for:
Massachusetts Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.